Project Grant HT9425261E106
Award Date 5/1/26
Completion Date 4/30/29
Dollars Obligated $1.6M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Rochester, NY 14611, USA
Similar Awards
- Federal Grant Award Summary The University of Rochester received a $1,173,575 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2029. This award funds research on Anticodon-Edited (ACE) transfer RNA (tRNA) treatment for nonsense-mediated Duchenne muscular dystrophy (DMD), a genetic disorder affecting muscle function. The research will be conducted at the University of...
- Federal Project Grant Award Summary The University of Rochester received a $369,109 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period August 1, 2025 through July 31, 2027. The award supports research titled "Driving Hearing Restoration with Virally Transduced, Pharmaceutically Activated TERBB2." This project delivers biomedical research and development services focused on developing innovative...
- The University of Rochester received a $812,602 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "IMAGING CANCER MICROENVIRONMENT HOT SPOTS INVOLVED IN PROGRESSION OF MYELODYSPLASTIC SYNDROMES." The research, which will take place from May 2024 to May 2027, aims to improve understanding of the cancer microenvironment and its role in the progression of myelodysplastic syndromes, a group of...
- Federal Grant Award Summary Health Research, Inc. (Roswell Park Division) received a $1.152M project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2029. The award funds research designed to leverage infiltrating myeloid cells to enhance therapeutic response to bite-secreting T cells in ovarian cancer treatment. This research initiative represents a translational oncology effort...
- Federal Grant Award Summary The University of Minnesota's Office of Sponsored Projects Administration received a $154,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2027. The award supports research and development activities focused on dual-targeting Glucocorticoid/Dendritic (G/D) Chimeric Antigen Receptor (CAR)-T cell therapy for treating rhabdomyosarcoma, a...
- Federal Grant Award Summary Health Research, Inc. (operating as Health Research At Roswell Park) received a $929,806 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025 through June 30, 2029. The award supports research focused on leveraging infiltrating myeloid cells to improve therapeutic response to bite-secreting T cells in ovarian cancer treatment. This four-year research initiative will be...
- Federal Project Grant Award Summary The Regents of the University of Minnesota received a $614,150 Project Grant awarded on July 1, 2025, by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The award supports a two-year research initiative titled "Enhancing Long-Term Persistence of CAR-NK Cells for Treatment of Solid Tumors," with performance through June 30, 2027, at the university's Minneapolis campus. This project addresses...
- Federal Project Grant Award Summary New York University School of Medicine received a $1.67M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded September 30, 2026, with completion targeted for September 29, 2029. The award funds research to identify and characterize pathways that prevent the emergence of drug-tolerant persisters—a critical challenge in antimicrobial and cancer therapeutic resistance. This...
- The University of Rochester was awarded a $6,292,954 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "Monitoring and Mitigation of Neurological Injuries to Optimize Resilience After Repetitive Head Impacts (MONITOR RHI)," supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The grant, with a period...
- Federal Project Grant Award Summary The University of Michigan's Office of Research and Sponsored Projects received a $1.7 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for a three-year performance period running from July 1, 2026, through June 30, 2029. The award funds research focused on targeted disruption of the ARP300 enhanceosome in prostate cancer using domain-alteration chimeras (DALTACs), representing...